Erlocent 100mg Tablet is an anticancer medicine used to treat certain types of cancer. Erlocent 100mg Tablet is used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer.
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Erlocent 100mg Tablet is indeed prescribed for patients with metastatic lung cancer or advanced-stage lung cancer. It is also used in the treatment of certain types of pancreatic cancer, usually in combination with other drugs.
Please keep in mind that the information provided here is based on the general usage and effects of the medication. Individual responses to the medicine may vary, so it is always best to consult with a healthcare professional for personalized advice and information.
It is generally not recommended to drink alcohol while taking Erlocent 100mg Tablet. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
Erlocent 100mg Tablet is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking Erlocent 100mg Tablet.
Erlocent 100mg Tablet is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the medicine based on your clinical condition.
Erlocent 100mg Tablet is unlikely to affect your ability to drive or operate machinery. If you experience any side effects while takingErlocent 100mg Tablet such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved
Erlocent 100mg Tablet is generally not recommended to use in patients with severe kidney disease. Consult your doctor before taking Erlocent 100mg Tablet.
Erlocent 100mg Tablet is generally not recommended to use in patients with severe liver disease. Consult your doctor before taking Erlocent 100mg Tablet.
Erlocent 100mg Tablet works by inhibiting the activity of the epidermal growth factor receptor (EGFR) protein, which is found on the surface of cells and is involved in the growth and proliferation of cancer cells. When EGFR is activated, it sends signals to the inside of the cell to grow and divide. Erlocent 100mg Tablet binds to the EGFR and prevents it from activating, thereby inhibiting the growth and proliferation of cancer cells.
Like all medications, Erlocent 100mg Tablet can cause side effects but does not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Common Side Effects of Erlocent 100mg Tablet
Non-small cell lung cancer: Erlocent 100mg Tablet is used to treat non-small cell lung cancer, which is a type of lung cancer that affects a large number of cells in the lung. The symptoms include persistent cough, chest pain, shortness of breath, hoarseness, unexplained weight loss, and fatigue
Pancreatic Cancer: Erlocent 100mg Tablet is used in combination with gemcitabine for the treatment of pancreatic cancer. The symptoms of pancreatic cancer can include abdominal pain, jaundice, weight loss, loss of appetite, nausea, vomiting, and fatigue.
Erlotinib is an epidermal growth factor receptor/human epidermal growth factor receptor type 1 (EGFR/HER1) tyrosine kinase inhibitor. It reversibly inhibits the kinase activity of EGFR, preventing autophosphorylation of tyrosine residues associated w/ the receptor, thereby inhibiting further downstream signaling and resulting in cell death.
Drug-Drug Interactions:
Drug-Food Interactions:
Drug-Disease Interactions: Erlotinib may interact differently or require special consideration in patients with the following conditions:
It's important to note that these interactions may vary depending on individual circumstances, dosages, and other factors. It's always best to consult with a healthcare professional or pharmacist for personalized advice and recommendations regarding specific interactions with erlotinib.
If you are allergic to erlotinib or any of the ingredients of Erlocent 100mg Tablet.
Based on animal data and the mechanism of action of erlotinib, it has the potential to cause harm to a developing fetus if administered to a pregnant woman. Therefore, it is important to advise females of reproductive potential to use effective contraception during treatment with erlotinib and for at least one month after the last dose.
Regarding lactation, there is no available data on the presence of erlotinib in human milk or its effects on breastfed infants or milk production. However, due to the potential for serious adverse reactions in breastfed infants, such as interstitial lung disease, hepatotoxicity, bullous and exfoliative skin disorders, microangiopathic hemolytic anemia with thrombocytopenia, ocular disorders, and diarrhea, it is advised that lactating women do not breastfeed during treatment with erlotinib and for two weeks after the final dose.
It's important for healthcare professionals to provide this information and guidance to pregnant women and lactating women who are considering or undergoing treatment with erlotinib
This medication should be kept in a cool dry place and in its original packaging. Make sure this medication remains unreachable to children and pets.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.